C4 Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx

Rhea-AI Summary

C4 Therapeutics (Nasdaq: CCCC), a biopharmaceutical pioneer in targeted protein degradation, will present at the Evercore ISI 3rd Annual HealthCONx on December 3, 2020, at 8:25 a.m. ET.

Investors can access a live webcast of the presentation on the company’s website, with a replay available for two weeks post-event. C4T focuses on therapeutics that selectively destroy disease-causing proteins, offering potential advantages over traditional treatments, particularly in cancer and neurodegenerative diseases.

WATERTOWN, Mass., Nov. 25, 2020 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new class of small-molecule drugs that selectively destroys disease-causing proteins through degradation, today announced that the Company will present at the Evercore ISI 3rd Annual HealthCONx on Thursday, December 3, 2020 at 8:25 a.m. ET.

A live webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the company’s website at www.c4therapeutics.com. A replay of the webcast will be archived on the C4T website for at least two weeks following the presentation.

About C4 Therapeutics
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. This targeted protein degradation approach offers advantages over traditional therapies, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity. To learn more about C4 Therapeutics, visit www.C4Therapeutics.com.

FAQ

When will C4 Therapeutics present at the Evercore ISI 3rd Annual HealthCONx?

C4 Therapeutics will present on December 3, 2020, at 8:25 a.m. ET.

How can I access the C4 Therapeutics presentation webcast?

The live webcast can be accessed in the 'Events & Presentations' section of C4 Therapeutics' website.

What is the focus of C4 Therapeutics' research?

C4 Therapeutics focuses on developing small-molecule drugs that selectively destroy disease-causing proteins, particularly for cancer and neurodegenerative conditions.

What advantages does C4 Therapeutics' approach offer over traditional therapies?

Their approach may treat a wider range of diseases, reduce drug resistance, achieve higher potency, and minimize side effects.

How long will the C4 Therapeutics presentation replay be available?

The replay of the presentation will be available for at least two weeks following the event.